All eyes on data on Biogen’s tau therapy
Biogen's experimental tau therapy diranersen shows promise in slowing cognitive decline for early Alzheimer's patients.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Biogen presented Phase 2 CELIA data at the Alzheimer's Association International Conference (AAIC) regarding its anti-tau oligonucleotide, diranersen. The data indicates robust tau reduction and meaningful clinical outcomes in patients with early Alzheimer's disease.
Coverage from STAT and Fierce Biotech emphasizes that the drug slowed cognitive decline at rates comparable to currently approved therapies. AP News reports the results as a sign of promise within the broader search for new treatment approaches.
Attention now turns to Biogen's potential pivotal push for the therapy following these Phase 2 results.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What is the name of the experimental drug?
The therapy is called diranersen.
Where were the Phase 2 CELIA data presented?
The data were presented at the Alzheimer's Association International Conference (AAIC).
How did the drug perform compared to other treatments?
According to STAT, the drug slowed cognitive decline at rates on par with approved therapies.
Coverage (5)
- AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline Fierce Biotech · 1d ago
- Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease Biogen · 1d ago
- Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows STAT · 1d ago
- An experimental Alzheimer's drug shows some promise as researchers hunt new approaches AP News · 1d ago
- All eyes on data on Biogen’s tau therapy STAT · 1d ago
Topics
Related trends
The 2 brain-healthy habits a neurologist swears by
New reports highlight a significant percentage of dementia cases that may be preventable through specific brain-healthy habits and risk management.
A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice
A drug candidate previously proven safe in humans has shown success in reducing multiple signs of Alzheimer's disease in mice.
Scientists Discover a Sign of Dementia up to 15 Years Before Diagnosis
Researchers have identified indicators of dementia and Alzheimer's disease that may appear up to 15 years before a formal diagnosis.
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the tuberculosis BCG vaccine may reduce Alzheimer's risk by remodeling the brain's immune environment.
I said yes to an Alzheimer’s blood test. Then I panicked.
New blood tests using circular RNAs and protein markers are enabling the detection of Alzheimer's risk decades before symptoms appear.
EXCLUSIVE: Danny Glover Reveals Alzheimer’s Diagnosis and Shares Update on Illness
Danny Glover's public revelation of his Alzheimer’s diagnosis has sparked widespread media coverage and public support.